Pharmabiz

CSI receives Japanese approval for Diamondback 360 Coronary OAS with Classic Crown & ViperWire Advance Coronary Guidewire FlexTip

Cardiovascular Systems, Inc. (CSI) a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, ...
Business Wire

First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamondback 360 ® Coronary Orbital Atherectomy System

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Business Wire

Data From Clinical Trial Evaluating Cardiovascular Systems’ Diamondback 360° to Treat Above-the-Knee Peripheral Arterial Disease to Be Presented at ACC

ST. PAUL, Minn.--(BUSINESS WIRE)--EMBARGOED UNTIL 9:30 A.M. CT, April 5, 2011 ACC i2 Poster Contributions Session No. 2516 (Poster #507) WHAT: Principal Investigator ...
Twin Cities Business

Cardiovascular Systems Posts First-Ever Quarterly Profit

Cardiovascular Systems’ revenues rose 21 percent to $50 million in the second quarter and reported a $1 million profit—its first so far this decade. Driven by an 18 percent year-over-year reduction in ...
KSL

Cardiovascular Systems Announces First Peripheral Arterial Disease Case Treated with New, Low-Profile, 60cm Diamondback Peripheral System

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...